The DOI matches its Crossref record; 95 of the 95 references it cites were found in a registry or an index.
The Complicated Relationship Between Attention Deficit/Hyperactivity Disorder and Substance Use Disorders
Open accessAbstract
Adolescents and young adults with substance use disorders (SUD) and attention deficit/hyperactivity disorder (ADHD) are increasingly presenting in clinical practice. The overlap and role of treatment for these co-occurring disorders remains unclear. A review of the literature was conducted to highlight and update recent evidence on the overlap of ADHD and SUD, the role of ADHD medication on later SUD, and the treatment of ADHD and SUD in adolescents and young adults. Recent work continues to highlight the high risk for comorbid ADHD in patients with SUD; and conversely, the high risk for SUD developing in ADHD across the lifespan, particularly in the context of comorbid conduct disorder. Although the data remains discordant, it appears that ADHD pharmacotherapy does not increase the risk for SUD. Medication treatment alone does not appear to be particularly effective in treating SUD in currently active substance abusing individuals with ADHD. Structured therapies may be effective in treating adolescents and young adults with ADHD and SUD. Further controlled trials evaluating the sequence and effect of structured psychotherapies and/or ADHD pharmacotherapy on SUD relapse in these groups are warranted.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“overuse of drug testing is more common in minoritized populations with SUD.199,200”
From The ASAM/AAAP Clinical Practice Guideline on the Management of Stimulant Use Disorder (2024) · cites this paper as [200]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Because drug testing is known to introduce potential bias against minoritized populations”
From The ASAM/AAAP Clinical Practice Guideline on the Management of Stimulant Use Disorder (2024) · cites this paper as [200]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Merikangas, K. R., He, J.-P., Burstein, M., Swanson, S. A., Avenevoli, S., Cui, L., Benjet, C., Georgiades, K., & Swendsen, J. (2010) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2010.05.017 · Cited by 6,278
The worldwide prevalence of ADHD: a systematic review and metaregression analysis
Polanczyk, G., de Lima, M. S., Horta, B. L., Biederman, J., & Rohde, L. A. (2007) · American Journal of Psychiatry · doi:10.1176/ajp.2007.164.6.942 · Cited by 5,346
Merikangas, K. R., He, J.-P., Burstein, M., Swendsen, J., Avenevoli, S., Case, B., Georgiades, K., Heaton, L., Swanson, S., & Olfson, M. (2011) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2010.10.006 · Cited by 1,579 · cited 4×
“Given that active SUD may exacerbate ADHD symptoms by as much as 30 % [61•], in patients who are not well known to the practitioner, a period of brief abstinence or low level use of substances is usually necessary to help establish a valid diagnosis [62]. As discussed elsewhere, the diagnosis of adolescents and young…”
BackgroundResultInfluentialMotivational interviewing with problem drinkers
Miller, W. R. (1983) · Behavioural Psychotherapy · doi:10.1017/s0141347300006583 · Cited by 1,390
Lee, S. S., Humphreys, K. L., Flory, K., Liu, R., & Glass, K. (2011) · Clinical Psychology Review · doi:10.1016/j.cpr.2011.01.006 · Cited by 875
Wilens, T. E., Faraone, S. V., Biederman, J., & Gunawardene, S. (2003) · Pediatrics · doi:10.1542/peds.111.1.179 · Cited by 872
Self-citationNeurobiology of attention-deficit hyperactivity disorder
Faraone, S. V., & Biederman, J. (1998) · Biological Psychiatry · doi:10.1016/s0006-3223(98)00240-6 · Cited by 811
The Cannabis Youth Treatment (CYT) Study: Main findings from two randomized trials
Dennis, M. L., Godley, S. H., Diamond, G., Tims, F. M., Babor, T. F., Donaldson, J., Liddle, H. A., Titus, J. C., Kaminer, Y., Webb, C. P. M., et al. (2004) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2003.09.005 · Cited by 780
Childhood predictors of adolescent substance use in a longitudinal study of children with ADHD
Molina, B. S. G., & Pelham, W. E. (2003) · Journal of Abnormal Psychology · doi:10.1037/0021-843x.112.3.497 · Cited by 706
Neurobiology of the Adolescent Brain and Behavior: Implications for Substance Use Disorders
Casey, B. J., & Jones, R. M. (2010) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2010.08.017 · Cited by 692
Research works printed but not linked: 1
- Katusic SK et al. Substance abuse among ADHD cases: a population-based birth cohort study. Seattle: Pediatric Academic Society; 2003.
Cited by
Sorted by citations
Items 201–213 of 213
Wilde, Z. C., Smith, S. D., Murphy, M. B., Underwood, J. J., Walbridge, F. C., Cotter, M. C., Pothoven, C., Harris, T., & Barry, C. T. (2025) · Journal of Child & Adolescent Trauma · doi:10.1007/s40653-025-00770-6 · Cited by 2
Singh, H., & Kok-Hwee, C. H. I. A. (2025) · The Asian Educational Therapist · doi:10.64663/aet.63
Motomura, Y., Hayashi, S., Kurose, R., Yoshida, H., Okada, T., & Higuchi, S. (2023) · Figshare · doi:10.6084/m9.figshare.24104294
Ward, J. H., McBride, A., Price, A., & Delgado, T. N. (2024) · Figshare · doi:10.6084/m9.figshare.26798802
Ward, J. H., McBride, A., Price, A., & Delgado, T. N. (2024) · Figshare · doi:10.6084/m9.figshare.26798796
Ward, J. H., McBride, A., Price, A., & Delgado, T. N. (2024) · Figshare · doi:10.6084/m9.figshare.26798799
Gjerstad, J., Solli, K. K., Tanum, L., Weimand, B. M., & Sannes, A. (2026) · Psychiatry International · doi:10.3390/psychiatryint7010028
Wudy, S., Mauche, N., Huang, J., Makiol, C., & Strauß, M. (2026) · Research Square · doi:10.21203/rs.3.rs-8518298/v1
Pappajohn, A. F., Seddio, A. E., Jahagirdar, O. B., Lee, A. H., Raju, A., Lee, C., & Grauer, J. N. (2026) · Spine Deformity · doi:10.1007/s43390-026-01350-w
ADHD and Suicide Risk Across Life Stages
Ayano, G., Pollard, C. M., Rooney, R. M., & Alati, R. (2026) · SpringerBriefs in modern perspectives on disability research. · doi:10.1007/978-981-95-8712-4_4
Khemchandani, M., & Deshmukh, M. P. (2026) · Applied Neuropsychology Adult · doi:10.1080/23279095.2026.2707490
Liu, M.-N., Chen, K.-C., Chen, M., Kuo, P., & Tsai, S. (2026) · Epidemiology and Psychiatric Sciences · doi:10.1017/s2045796026100936
“The disorders examined included schizophrenic disorders, MDD, depressive disorders, bipolar disorder, panic disorder, OCD, GAD, ADHD and dementia.”
InfluentialVictor, M. M. (2014) · Americanae (AECID Library)
Metadata
- Authors
- Zulauf, C. A., Sprich, S. E., Safren, S. A., & Wilens, T. E.
- Affiliations
- Massachusetts General Hospital (US)
- Corresponding author
- Wilens, Timothy E.
- Venue
- Current Psychiatry Reports
- Published
- 2014-02-15
- Volume
- 16
- Issue
- 3
- Pages
- 436-436
- ISSN
- 1523-3812 (ISSN-L)
- 1535-1645
- PMC
- PMC4414493
- OpenAlex
- W2025736977
- Cited by
- 214
- References
- 94
- Citations by year
- 2026: 9 · 2025: 27 · 2024: 24 · 2023: 19 · 2022: 15 · 2021: 13 · 2020: 42 · 2019: 13 · 2018: 14 · 2017: 16 · 2016: 13 · 2015: 5 · 2014: 4
- FWCI
- 1.75
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Current Psychiatry Reports (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institute of Mental Health (K24MH094214)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Attention Deficit Hyperactivity Disorder
- Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Opioid Use Disorder Treatment
- Keywords
- attention deficit hyperactivity disorder, substance use disorders, comorbidities, adolescents, young adults, ADHD medication, conduct disorder, psychotherapy, relapse prevention
- MeSH terms
- Adolescent, Antidepressive Agents, Attention Deficit Disorder with Hyperactivity, Central Nervous System Agents, Clinical Trials as Topic, Humans, Psychotherapy, Risk Factors, Diagnosis, Dual (Psychiatry), Adrenergic Uptake Inhibitors, Substance-Related Disorders, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
